| 3.01 -0.29 (-8.79%) | 01-26 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 3.63 |
1-year : | 3.88 |
| Resists | First : | 3.1 |
Second : | 3.32 |
| Pivot price | 3.05  |
|||
| Supports | First : | 2.75 |
Second : | 2.29 |
| MAs | MA(5) : | 3.08 |
MA(20) : | 2.99 |
| MA(100) : | 3.56 |
MA(250) : | 4.63 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 67.5 |
D(3) : | 69.6 |
| RSI | RSI(14): 46 |
|||
| 52-week | High : | 8.03 | Low : | 2.75 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ NNOX ] has closed above bottom band by 37.1%. Bollinger Bands are 67.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 14 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 3.29 - 3.31 | 3.31 - 3.32 |
| Low: | 2.93 - 2.95 | 2.95 - 2.96 |
| Close: | 2.98 - 3.01 | 3.01 - 3.03 |
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company develops a prototype of the Nanox.ARC, a medical imaging system incorporating its digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that would allow for the delivery of medical screening as a service. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company was founded in 2011 and is headquartered in Neve Ilan, Israel.
Thu, 22 Jan 2026
Nanox Expands Distribution of Nanox.ARC Imaging System to Western Balkans - Yahoo Finance
Wed, 14 Jan 2026
Nanox Imaging (NNOX) Secures Exclusive Partnership in Southeast Europe - GuruFocus
Wed, 14 Jan 2026
Nanox Imaging Partners with Adriamed to Expand Medical Imaging Solutions in Southeast Europe - Quiver Quantitative
Mon, 05 Jan 2026
Nanox Imaging to Acquire VasoHealthcare IT for U.S. AI Expansion - MSN
Thu, 27 Nov 2025
Nano-X Imaging Remains Underwhelming Despite Recent Wins (NNOX) - Seeking Alpha
Sun, 23 Nov 2025
Nanox Announces $15 Million Registered Direct Offering of Common Stock - GlobeNewswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 65 (M) |
| Shares Float | 65 (M) |
| Held by Insiders | 0.2 (%) |
| Held by Institutions | 19.5 (%) |
| Shares Short | 8,390 (K) |
| Shares Short P.Month | 7,090 (K) |
| EPS | -0.88 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.4 |
| Profit Margin | 0 % |
| Operating Margin | -413 % |
| Return on Assets (ttm) | -20.1 % |
| Return on Equity (ttm) | -34.8 % |
| Qtrly Rev. Growth | 13.6 % |
| Gross Profit (p.s.) | -0.19 |
| Sales Per Share | 0.18 |
| EBITDA (p.s.) | -0.71 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -41 (M) |
| Levered Free Cash Flow | -27 (M) |
| PE Ratio | -3.43 |
| PEG Ratio | 0 |
| Price to Book value | 1.25 |
| Price to Sales | 15.99 |
| Price to Cash Flow | -4.82 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|